Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Cardiac structure and function and arterial circulation in hypertensive patients with and without metabolic syndrome

Abstract

High blood pressure (BP) is one of the crucial determinants of the metabolic syndrome (MS). The extent to which MS, diagnosed according to the criteria of the International Federation of Diabetes, impacts on cardiovascular organ damage, independently of BP, is debated. Three hundred and forty hypertensive patients and 100 normotensive controls underwent the following procedures: (1) physical examination and resting BP measurements, (2) 24 h ambulatory BP monitoring, (3) laboratory routine examination, (4) echocardiography, (5) carotid ultrasonography and (6) ankle-brachial BP index. The syndrome was found in 104 of the 340 hypertensive patients (30.6). In comparison to those without MS, those with MS had significantly higher prevalence of left ventricular (LV) hypertrophy by mass/height2.7 criteria (46 vs 42%, P<0.01) but not by LV mass/body surface criteria (30 vs 31%); the ratio between early-to-late peak velocities of the LV filling waves (E/A) was higher (E/A=0.99±0.14 vs 0.89±0.15, P<0.01) and left atrium was larger (3.8±0.3 vs 3.5±0.5 cm, P<0.01). Both hypertensive groups had significantly greater LVM and carotid intima-media thickness than normotensives, without between-group-difference. In this hypertension outpatient clinic almost one-third hypertensive patients have MS. They show a deterioration in structure and function of the heart in comparison to hypertensive patients without MS, but no difference was detected in the carotid and peripheral arterial circulation.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Peter Libby, Julie E. Buring, … Eldrin F. Lewis

References

  1. Reaven GM . Syndrome X: 6 years later. J Intern Med 1994; 236 (Suppl 736): 13–22.

    Google Scholar 

  2. Kesaniemi YA, Lilja M, Kervinen K, Rantala A . Multiple metabolic syndrome: aspects of genetic epidemiology and molecular genetics. Ann Med 1992; 24: 461–464.

    Article  CAS  Google Scholar 

  3. Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G . A metabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities baseline study. Diabetes Care 1996; 19: 414–418.

    Article  CAS  Google Scholar 

  4. Kaplan NM . The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 1989; 149: 1514–1520.

    Article  CAS  Google Scholar 

  5. World Health Organization. Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. WHO: Geneva, 1999.

  6. Mitka M . Does the metabolic syndrome really exist? Diabetes and heart disease groups spar over issue. JAMA 2005; 294: 2010–2013.

    Article  CAS  Google Scholar 

  7. Executive Summary. The third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult treatment Panel III). JAMA 2001; 285: 2486–2497.

    Article  Google Scholar 

  8. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS, et al., European Group For The Study Of Insulin Resistance (EGIR). Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002; 28: 364–376.

    PubMed  Google Scholar 

  9. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003; 9: 237–252.

    PubMed  Google Scholar 

  10. Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. The metabolic syndrome – a new worldwide definition. Lancet 2005; 366: 1059–1062.

    Article  Google Scholar 

  11. Ferrara LA, Guida L, Pasanisi F, Celentano A, Palmieri V, Iannuzzi R et al. Isolated office hypertension and end organ damage. J Hypertens 1997; 15: 979–985.

    Article  CAS  Google Scholar 

  12. Friedewald WT, Lery RI, Fredrickson DS . Estimation of plasma low density lipoprotein cholesterol concentration without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.

    CAS  PubMed  Google Scholar 

  13. Sahn DJ, De Maria A, Kisslo J, Weyman A . The Committee on M-mode standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–1083.

    Article  CAS  Google Scholar 

  14. Devereux RB, Reichek N . Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613–618.

    Article  CAS  Google Scholar 

  15. Ferrara LA, Vaccaro O, Cardoni O, Laurenzi M, Mancini M, Zanchetti A . Indexation criteria of ventricular mass and predictive role of blood pressure and body composition. Am J Hypertens 2005; 18: 1282–1287.

    Article  Google Scholar 

  16. Devereux RB, Dahlof B, Levy D, Pfeffer MA . Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial). Am J Cardiol 1996; 78: 61–65.

    Article  CAS  Google Scholar 

  17. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992; 20: 1251–1260.

    Article  CAS  Google Scholar 

  18. Teichholz LE, Kreulen T, Herman MV, Gorlin R . Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asinergy. Am J Cardiol 1976; 37: 7–11.

    Article  CAS  Google Scholar 

  19. Wallerson DC, Ganau A, Roman MJ, Devereux RB . Measurements of cardiac output by M-mode and two dimensional echocardiography: application to patients with hypertension. Eur Heart J 1990; 11 (Suppl 1): 67–78.

    Article  Google Scholar 

  20. Kuo LC, Quinones MA, Rokey R, Sartori M, Abinader EG, Zoghbi WA . Quantification of atrial contribution to left ventricular filling by pulsed Doppler echocardiography and the effect of age in normal and diseased hearts. Am J Cardiol 1987; 59: 1174–1178.

    Article  CAS  Google Scholar 

  21. Bond MG, Wilmoth SK, Enevold GL, Strickland HL . Detection and monitoring of asymptomatic atherosclerosis in clinical trials. Am J Med 1989; 86 (Suppl 4A): 33–36.

    Article  CAS  Google Scholar 

  22. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R . Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399–1406.

    Article  CAS  Google Scholar 

  23. Ferrara LA, Mancini M, Celentano A, Galderisi M, Iannuzzi R, Marotta T et al. Early changes of the arterial carotid wall in uncomplicated primary hypertensive patients. Study by ultrasound high-resolution B-mode imaging. Arterioscl Thromb 1994; 14: 1290–1296.

    Article  CAS  Google Scholar 

  24. Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E et al. Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 2004; 22: 1991–1998.

    Article  CAS  Google Scholar 

  25. Ferrara LA, Vaccaro O, Cardoni O, Mancini M, Zanchetti A . Metabolic syndrome and left ventricular mass in the Gubbio Population Study. J Hypertens 2005; 23 (Suppl 2): S133.

    Google Scholar 

  26. Kahn R, Buse J, Ferrannini E, Stern M, American Diabetes Association; European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28: 2289–2304.

    Article  Google Scholar 

  27. Eckel RH, Grundy SM, Zimmet PZ . The metabolic syndrome. Lancet 2005; 365: 1415–1428.

    Article  CAS  Google Scholar 

  28. Chinali M, Devereux RB, Howard BV, Roman MJ, Bella JN, Liu JE et al. Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study). Am J Cardiol 2004; 93: 40–44.

    Article  Google Scholar 

  29. Cuspidi C, Meani S, Valerio C, Fusi V, Catini E, Sala C et al. Ambulatory blood pressure, target organ damage and left atrial size in never-treated essential hypertensive individuals. J Hypertens 2005; 23: 1589–1595.

    Article  CAS  Google Scholar 

  30. Guida L, Celentano A, Iannuzzi R, Ferrara LA . Insulin resistance, ventricular mass and function in normoglycaemic hypertensives. Nutr Metab Cardiovasc Dis 2001; 11: 306–311.

    CAS  PubMed  Google Scholar 

  31. Grandi AM, Piantanida E, Franzetti I, Bernasconi M, Maresca A, Marnini P et al. Effect of glycemic control on left ventricular diastolic function in type 1 diabetes mellitus. Am J Cardiol 2006; 97: 71–76.

    Article  CAS  Google Scholar 

  32. Devereux RB, de Simone G, Pickering TG, Schwartz JE, Roman MJ . Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function. Hypertension 1998; 31: 929–936.

    Article  CAS  Google Scholar 

  33. Burchfiel CM, Skelton TN, Andrew ME, Garrison RJ, Arnett DK, Jones DW et al. Metabolic syndrome and echocardiographic left ventricular mass in blacks: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2005; 112: 819–827.

    Article  Google Scholar 

  34. Gariepy J, Massonneau M, Levenson J, Heudes D, Simon A . Evidence for in vivo carotid and femoral wall thickening in human hypertension. Groupe de Prevention Cardio-vasculaire en Medecine du Travail. Hypertension 1993; 22: 111–118.

    Article  CAS  Google Scholar 

  35. Su TC, Lee YT, Chou S, Chen CF, Wang JD . Twenty-four-hour ambulatory blood pressure and duration of hypertension as major determinants for intima-media thickness and atherosclerosis of carotid arteries. Atherosclerosis 2006; 184: 151–156.

    Article  CAS  Google Scholar 

  36. Zakopoulos NA, Tsivgoulis G, Barlas G, Papamichael C, Spengos K, Manios E et al. Time rate of blood pressure variation is associated with increased common carotid artery intima-media thickness. Hypertension 2005; 45: 505–512.

    Article  CAS  Google Scholar 

  37. Kawamoto R, Tomita H, Oka Y, Ohtsuka N, Kamitani A . Metabolic syndrome and carotid atherosclerosis: role of elevated blood pressure. J Atheroscler Thromb 2005; 12: 268–275.

    Article  CAS  Google Scholar 

  38. Ferrara LA, Mancini M, Iannuzzi R, Marotta T, Gaeta I, Pasanisi F et al. Carotid diameter and blood flow velocities in cerebral circulation in hypertensive patients. Stroke 1995; 26: 418–421.

    Article  CAS  Google Scholar 

  39. Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ, Visseren FL, the SMART Study Group. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J 2004; 25: 342–348.

    Article  Google Scholar 

  40. Costa LA, Canani LH, Lisboa HR, Tres GS, Gross JL . Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes. Diabet Med 2004; 21: 252–255.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L A Ferrara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferrara, L., Guida, L., Ferrara, F. et al. Cardiac structure and function and arterial circulation in hypertensive patients with and without metabolic syndrome. J Hum Hypertens 21, 729–735 (2007). https://doi.org/10.1038/sj.jhh.1002222

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1002222

Keywords

This article is cited by

Search

Quick links